- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$75.04 MnMarket Estimate, 2026
$78.36 MnMarket Forecast, 2034
$110.84 MnCAGR, 2026–2034
4.43%Middle East and Africa Soy Isoflavones Market Size, Growth, Trends & Forecast (2026–2034)
The Middle East and Africa soy isoflavones market size was valued at USD 75.04 million in 2025, is estimated at USD 78.36 million in 2026, and is projected to reach USD 110.84 million by 2034, registering a compound annual growth rate (CAGR) of 4.43% during the forecast period. Driven by rising health awareness regarding dietary soy consumption, expanding applications in the pharmaceutical and cosmetics sectors, and its proven anti-oxidant and cardiovascular-protective properties, the regional market continues its steady expansion.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 75.04 Million
- 2026 Current Valuation: USD 78.36 Million
- 2034 Forecast Valuation: USD 110.84 Million
- Compound Annual Growth Rate (CAGR): 4.43% (2026–2034)
- Dominant Application Sector: Nutraceuticals (widely utilized in dietary supplements and pharmaceutical formulations)
- Key Country Markets: UAE, Israel, KSA, South Africa, and Egypt
Core Market Drivers
- Medical & Therapeutic Demand: Increasing usage from pharmaceutical and medical industries due to antioxidant properties protecting against bad cholesterol, atherosclerosis, and cancer cell proliferation.
- Cosmetics Sector Growth: Expanding incorporation of soy isoflavones in skin-care formulations for sun damage protection, skin firming, wrinkle reduction, and deep moisturization.
- Preventive Healthcare: Rising awareness regarding the prevention of heart-related conditions, diabetes, and asthma through diet.
Primary Market Restraints & Challenges
- Side Effects of Overconsumption: Potential adverse reactions such as migraines, food allergies, and thyroid disorders resulting from excessive intake.
Middle East and Africa Soy Isoflavones Market Segmentation Breakdown
| Segment Category | Leading Sub-Segment (2025 Base) | Fastest-Growing Sub-Segment (2026–2034) |
|---|---|---|
| By Application | Nutraceuticals & Dietary Supplements | Cosmetics & Personal Care |
| By Form | Powder Form | Liquid & Wax Formulations |
| By Raw Material | Non-Genetically Modified (Non-GM) | Genetically Modified (GM) Extracts |
| By Product Type | Genistein & Daidzein | Glucitein |
| By Country | UAE, Israel, & KSA (key economic hubs) | South Africa & Egypt |
Major Industry Players Profiled
Key enterprises shaping the competitive Middle East and Africa soy isoflavones market include Fujicco Co., Ltd, Aushadhi Herbal, Tradichem S.L, Frutarom Ltd., Archer Daniels Midland, SK Bioland, Medisys Biotech Pvt. Ltd., Guzen Development, Nutra Green Biotechnology Co., Ltd., and HerboNutra.
Middle East and Africa Soy Isoflavones Market Size
The Middle East and Africa soy isoflavones market size was valued at USD 75.04 million in 2025 and is projected to reach USD 110.84 million by 2034 from USD 78.36 million in 2026, growing at a CAGR of 4.43%.
MARKET OVERVIEW
Isoflavones are phytoestrogens have a similar chemical structure to the hormone estrogen. Isoflavones may have estrogens or anti-estrogenic effects and so it is considered as a SERM (Selective Estrogen Receptor Modulators). The soy Isoflavones is potentially a very rich source of estrogen and vitamin E and possess properties like anti-oxidant and breast cancer cells suppressor. Soy Isoflavones is produced from the leaf, bark, seed, and shell of soy plant and the end products of soy Isoflavones can be made available in the form of powder, oil or wax. The increasing awareness about the consumption of soy Isoflavones in the diet and its benefits like prevention and cure of heart-related diseases, multiple cancers, asthma, and diabetes are the major factors driving the demand of soy Isoflavones worldwide.
The Middle East and Africa soy Isoflavones market is anticipated to register a considerable CAGR over the aforementioned forecast period owing to the increasing demand of soy Isoflavones from the pharmaceutical and medical industries. Soy Isoflavones has the properties like antioxidant along with protecting against the bad cholesterol and atherosclerosis in cardiovascular diseases, thereby driving the demand of the soy Isoflavones market. The consumption of soy Isoflavones through food and food supplements reduces the risk of growth of cancer cells by reducing cell mitosis process. The growing demand of soy Isoflavones from cosmetics industry for protect sun damage, treating skin firming, wrinkles, and moisturize skin which also drives the Middle East and Africa soy Isoflavones market.
But still, the overconsumption of soy Isoflavones leads to the side effects like migraine, food allergies, and thyroid disorder and may hinder the use of the soy Isoflavones and restrain the Middle East and Africa soy Isoflavones market.
MARKET SEGMENTATION
This research report on the Middle East and Africa soy isoflavones market has been segmented and sub-segmented into the following categories.
By Application
-
Food and Beverages
-
Nutraceutical
-
Cosmetics
Nutraceutical was the leading application sector and accounted for USD 5.14 billion in 2015. Isoflavones extract is widely used in dietary supplements, nutraceutical, and pharmaceutical industries.
By Form
-
liquid
-
wax
By Raw Material
- Genetically Modified (GM)
- Non-genetically Modified (Non-GM)
By Product Type
- Genistein
- Daidzein
- Glucitein
By Country
-
UAE
-
Israel
-
KSA
-
South Africa
-
Egypt
KEY MARKET PLAYERS
- Fujicco Co., Ltd
- Aushadhi Herbal
- Tradichem S.L
- Frutarom Ltd.
- Archer Daniels Midland
- SK Bioland
- Medisys Biotech Pvt. Ltd.
- Guzen Development
- Nutra Green Biotechnology Co., Ltd.
- HerboNutra